Ted Cole, DO - The Use of LDN and Amino Acids in Parkinson's Disease (2019 Conference) (LDN, low dose naltrexone)
Presented n a novel way of addressing relative nutritional deficiencies and inflammation in Parkinson's Disease which can reverse all symptoms related to these issues.
Session Learning Objective:
Understand the proper use of nutrients and LDN in addressing inflammation and relative nutritional deficiencies in Parkinson's Disease
- Description of the relative nutritional deficiencies involved in Parkinson's Disease
- Inflammation as a factor in the progression of symptoms and how to treat it with LDN and nutrients
- The basic science of amino acid therapy addressing the neurotransmitter and methylation systems
- Nutritional agents used and the proper method of administration and testing
Ted Cole, DO discusses the use of LDN in Parkinson’s disease. He begins with deficient agents associated with Parkinson’s, the major issue of inflammation and the importance of early therapeutic intervention with neuroprotective drugs. He presents disabling symptoms of Parkinson’s, and talks about LDN therapy.